Superiority of in vitro nondonor-specific immune monitoring over donor-specific assays in detecting a prerejection state.
D000208:Acute Disease; D000920:Antibody-Dependent Cell Cytotoxicity; D003362:Cost-Benefit Analysis; D003601:Cytotoxicity Tests, Immunologic; D006084:Graft Rejection; D016027:Heart Transplantation; D006801:Humans; D007158:Immunologic Techniques; D016030:Kidney Transplantation; D013601:T-Lymphocytes / Q000276:immunology; D014184:Transplantation, Homologous